NurkS, KorenS, RhieA, et al.The complete sequence of a human genome. Science, 2022; 376(6588):44–53; doi: 10.1126/science.abj6987
2.
YuB, WangS. Angio-LncRs: LncRNAs that regulate angiogenesis and vascular disease. Theranostics, 2018; 8(13):3654–3675; doi: 10.7150/thno.26024
3.
LiQ, PangL, YangW, et al.Long non-coding RNA of myocardial infarction associated transcript (LncRNA-MIAT) promotes diabetic retinopathy by upregulating transforming growth factor-β1 (TGF-β1) signaling. Med Sci Monit, 2018; 24:9497–9503; doi: 10.12659/MSM.911787
4.
YanB, YaoJ, LiuJY, et al.lncRNA-MIAT regulates microvascular dysfunction by functioning as a competing endogenous RNA. Circ Res, 2015; 116(7):1143–1156; doi: 10.1161/CIRCRESAHA.116.305510
5.
ZhangJ, ChenM, ChenJ, et al.Long non-coding RNA MIAT acts as a biomarker in diabetic retinopathy by absorbing. Biosci Rep, 2017; 37(2):BSR20170036; doi: 10.1042/BSR20170036
6.
YuC, YangK, MengX, et al.Downregulation of long noncoding RNA MIAT in the retina of diabetic rats with tail-vein injection of human umbilical-cord mesenchymal stem cells. Int J Med Sci, 2020; 17(5):591–598; doi: 10.7150/ijms.38078
7.
BiswasS, CoyleA, ChenS, et al.Expressions of serum lncRNAs in diabetic retinopathy—A potential diagnostic tool. Front Endocrinol (Lausanne), 2022; 13:851967; doi: 10.3389/fendo.2022.851967
8.
WeiJC, ShiYL, WangQ. LncRNA ANRIL knockdown ameliorates retinopathy in diabetic rats by inhibiting the NF-kappaB pathway. Eur Rev Med Pharmacol Sci, 2019; 23(18):7732–7739; doi: 10.26355/eurrev_201909_18982
9.
WangHS, WangL, TangLY, et al.Long noncoding RNA SNHG6 promotes proliferation and angiogenesis of cholangiocarcinoma cells through sponging miR-101-3p and activation of E2F8. J Cancer, 2020; 11(10):3002–3012; doi: 10.7150/jca.40592
10.
ZhaoW, FuH, ZhangS, et al.LncRNA SNHG16 drives proliferation, migration, and invasion of hemangioma endothelial cell through modulation of miR-520d-3p/STAT3 axis. Cancer Med-Us, 2018; 7(7):3311–3320; doi: 10.1002/cam4.1562
11.
CaiF, JiangH, LiY, et al.Upregulation of long non-coding RNA SNHG16 promotes diabetes-related RMEC dysfunction via activating NF-kappaB and PI3K/AKT pathways. Mol Ther Nucleic Acids, 2021; 24:512–527; doi: 10.1016/j.omtn.2021.01.035
12.
ZhangR, MaX, JiangL, et al.Decreased lncRNA SNHG16 accelerates oxidative stress induced pathological angiogenesis in human retinal microvascular endothelial cells by regulating miR-195/mfn2 Axis. Curr Pharm Des, 2021; 27(27):3047–3060; doi: 10.2174/1381612827666210202141541
13.
AtefMM, ShafikNM, HafezYM, et al.The evolving role of long noncoding RNA HIF1A-AS2 in diabetic retinopathy: A cross-link axis between hypoxia, oxidative stress and angiogenesis via MAPK/VEGF-dependent pathway. Redox Rep, 2022; 27(1):70–78; doi: 10.1080/13510002.2022.2050086
BiswasS, FengB, ChenS, et al.The long non-coding RNA HOTAIR is a critical epigenetic mediator of angiogenesis in diabetic retinopathy. Invest Ophthalmol Vis Sci, 2021; 62(3):20; doi: 10.1167/iovs.62.3.20
16.
LiuJY, YaoJ, LiXM, et al.Pathogenic role of lncRNA-MALAT1 in endothelial cell dysfunction in diabetes mellitus. Cell Death Dis, 2014; 5(10):e1506; doi: 10.1038/cddis.2014.466
17.
YanB, TaoZF, LiXM, et al.Aberrant expression of long noncoding RNAs in early diabetic retinopathy. Invest Ophthalmol Vis Sci, 2014; 55(2):941–951; doi: 10.1167/iovs.13–13221
18.
XiaF, XuY, ZhangX, et al.Competing endogenous RNA network associated with oxygen-induced retinopathy: Expression of the network and identification of the MALAT1/miR-124-3p/EGR1 regulatory axis. Exp Cell Res, 2021; 408(1):112783; doi: 10.1016/j.yexcr.2021.112783
19.
YuL, FuJ, YuN, et al.Long noncoding RNA MALAT1 participates in the pathological angiogenesis of diabetic retinopathy in an oxygen-induced retinopathy mouse model by sponging miR-203a-3p. Can J Physiol Pharmacol, 2020; 98(4):219–227; doi: 10.1139/cjpp-2019-0489
20.
XuXD, LiKR, LiXM, et al.Long non-coding RNAs: New players in ocular neovascularization. Mol Biol Rep, 2014; 41(7):4493–4505; doi: 10.1007/s11033-014-3320-5
21.
QiuGZ, TianW, FuHT, et al.Long noncoding RNA-MEG3 is involved in diabetes mellitus-related microvascular dysfunction. Biochem Biophys Res Commun, 2016; 471(1):135–141; doi: 10.1016/j.bbrc.2016.01.164
22.
RuanW, ZhaoF, ZhaoS, et al.Knockdown of long noncoding RNA MEG3 impairs VEGF-stimulated endothelial sprouting angiogenesis via modulating VEGFR2 expression in human umbilical vein endothelial cells. Gene, 2018; 649:32–39; doi: 10.1016/j.gene.2018.01.072
23.
ZhangD, QinH, LengY, et al.LncRNA MEG3 overexpression inhibits the development of diabetic retinopathy by regulating TGF-β1 and VEGF. Exp Ther Med, 2018; 16(3):2337–2342; doi: 10.3892/etm.2018.6451
24.
ChenJ, LiaoL, XuH, et al.Long non-coding RNA MEG3 inhibits neovascularization in diabetic retinopathy by regulating microRNA miR-6720-5p and cytochrome B5 reductase 2. Bioengineered, 2021; 12(2):11872–11884: doi: 10.1080/21655979.2021.2000721
25.
ShiL, HanX, LiuC, et al.Long non-coding RNA PNKY modulates the development of choroidal neovascularization. Front Cell Dev Biol, 2022; 10:836031; doi: 10.3389/fcell.2022.836031
26.
ZhouQ, YuB, AndersonC, et al.LncEGFL7OS regulates human angiogenesis by interacting with MAX at the EGFL7/miR-126 locus. Elife, 2019; 8:e40470; doi: 10.7554/eLife.40470
27.
BadenLR, El SahlyHM, EssinkB, et al.Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med, 2021; 384(5):403–416; doi: 10.1056/NEJMoa2035389
28.
WinkleM, El-DalySM, FabbriM, et al.Noncoding RNA therapeutics—Challenges and potential solutions. Nat Rev Drug Discov, 2021; 20(8):629–651; doi: 10.1038/s41573-021-00219-z
29.
QuL, YiZY, ShenY, et al.Circular RNA vaccines against SARS-CoV-2 and emerging variants. Cell, 2022; 185(10):1728–1744.e16; doi: 10.1016/j.cell.2022.03.044
30.
AbulwerdiFA, XuW, AgeeliAA, et al.Selective small-molecule targeting of a triple helix encoded by the long noncoding RNA, MALAT1. ACS Chem Biol, 2019; 14(2):223–235; doi: 10.1021/acschembio.8b00807
